These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38214106)

  • 1. Paclitaxel-loaded niosomes in combination with metformin: development, characterization and anticancer potentials.
    Al-Kofahi T; Altrad B; Amawi H; Aljabali AA; Abul-Haija YM; Obeid MA
    Ther Deliv; 2024 Feb; 15(2):109-118. PubMed ID: 38214106
    [No Abstract]   [Full Text] [Related]  

  • 2. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
    Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
    Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities.
    Haddadian A; Robattorki FF; Dibah H; Soheili A; Ghanbarzadeh E; Sartipnia N; Hajrasouliha S; Pasban K; Andalibi R; Ch MH; Azari A; Chitgarzadeh A; Kashtali AB; Mastali F; Noorbazargan H; Mirzaie A
    Sci Rep; 2022 Dec; 12(1):21938. PubMed ID: 36536030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Evaluation of Paclitaxel-Loaded PEGylated Niosomes Composed of Sorbitan Esters.
    Hosokawa M; Ito S; Noda K; Kono Y; Ogawara KI
    Biol Pharm Bull; 2023; 46(10):1479-1483. PubMed ID: 37779050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of doxorubicin and paclitaxel via noisome nanocarriers attenuates cancerous phenotypes in gastric cancer cells.
    Rezaei N; Kazem Arki M; Miri-Lavasani Z; Solhi R; Khoramipour M; Rashedi H; Asadzadeh Aghdaei H; Hossein-Khannazer N; Mostafavi E; Vosough M
    Eur J Pharm Biopharm; 2023 Jul; 188():33-47. PubMed ID: 37105361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
    Hasan AA; Madkor H; Wageh S
    Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel loaded niosome nanoparticle formulation prepared via reverse phase evaporation method: an in vitro evaluation.
    Zarei M; Norouzian D; Honarvar B; Mohammadi M; Shamabadi HE; Akbarzadeh A
    Pak J Biol Sci; 2013 Mar; 16(6):295-8. PubMed ID: 24498794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, Characterization and
    Patel P; Barot T; Kulkarni P
    Curr Drug Deliv; 2020; 17(3):257-268. PubMed ID: 32056523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies.
    El-Far SW; Abo El-Enin HA; Abdou EM; Nafea OE; Abdelmonem R
    Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression.
    Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N
    Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and in vitro anti skin aging activity and UV radiation protection of morin loaded in niosomes.
    Mohamadi N; Soltanian S; Raeiszadeh M; Moeinzadeh M; Ohadi M; Sharifi F; Pardakhty A; Sharififar F
    J Cosmet Dermatol; 2022 Nov; 21(11):6326-6335. PubMed ID: 35876761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
    Bayindir ZS; Yuksel N
    J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
    Narayanaswamy R; Torchilin VP
    Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes.
    Barani M; Hajinezhad MR; Sargazi S; Rahdar A; Shahraki S; Lohrasbi-Nejad A; Baino F
    J Mater Sci Mater Med; 2021 Dec; 32(12):147. PubMed ID: 34862910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
    Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer.
    Burande AS; Viswanadh MK; Jha A; Mehata AK; Shaik A; Agrawal N; Poddar S; Mahto SK; Muthu MS
    AAPS PharmSciTech; 2020 May; 21(5):151. PubMed ID: 32440910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Microfluidic Preparation of Niosomes for Targeted Drug Delivery.
    Ag Seleci D; Maurer V; Stahl F; Scheper T; Garnweitner G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines.
    Pourmoghadasiyan B; Tavakkoli F; Beram FM; Badmasti F; Mirzaie A; Kazempour R; Rahimi S; Larijani SF; Hejabi F; Sedaghatnia K
    Mol Biol Rep; 2022 May; 49(5):3597-3608. PubMed ID: 35235156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.
    Obeid MA; Khadra I; Albaloushi A; Mullin M; Alyamani H; Ferro VA
    Beilstein J Nanotechnol; 2019; 10():1826-1832. PubMed ID: 31579065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.